These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8915604)

  • 1. Proteoglycans and amyloid fibrillogenesis.
    Kisilevsky R; Fraser P
    Ciba Found Symp; 1996; 199():58-67; discussion 68-72, 90-103. PubMed ID: 8915604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amyloidogenesis: historical and modern observations point to heparan sulfate proteoglycans as a major culprit.
    Ancsin JB
    Amyloid; 2003 Jun; 10(2):67-79. PubMed ID: 12964414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel glycosaminoglycan precursors as anti-amyloid agents part II.
    Kisilevsky R; Szarek WA
    J Mol Neurosci; 2002; 19(1-2):45-50. PubMed ID: 12212792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of perlecan gene expression precedes amyloid formation during experimental murine AA amyloidogenesis.
    Ailles L; Kisilevsky R; Young ID
    Lab Invest; 1993 Oct; 69(4):443-8. PubMed ID: 8231112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparan sulfate as a therapeutic target in amyloidogenesis: prospects and possible complications.
    Kisilevsky R; Ancsin JB; Szarek WA; Petanceska S
    Amyloid; 2007 Mar; 14(1):21-32. PubMed ID: 17453622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Localization of the basement membrane heparan sulfate proteoglycan in islet amyloid deposits in type II diabetes mellitus.
    Young ID; Ailles L; Narindrasorasak S; Tan R; Kisilevsky R
    Arch Pathol Lab Med; 1992 Sep; 116(9):951-4. PubMed ID: 1524461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of heparan sulfate glycosaminoglycan to beta-amyloid peptide: inhibition by potentially therapeutic polysulfated compounds.
    Leveugle B; Scanameo A; Ding W; Fillit H
    Neuroreport; 1994 Jun; 5(11):1389-92. PubMed ID: 7522615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-deposition of basement membrane components during the induction of murine splenic AA amyloid.
    Lyon AW; Narindrasorasak S; Young ID; Anastassiades T; Couchman JR; McCarthy KJ; Kisilevsky R
    Lab Invest; 1991 Jun; 64(6):785-90. PubMed ID: 2046330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of proteoglycans associated with mouse splenic AA amyloidosis.
    Stenstad T; Magnus JH; Husby G
    Biochem J; 1994 Oct; 303 ( Pt 2)(Pt 2):663-70. PubMed ID: 7980430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of vascular heparan sulfate proteoglycan to Alzheimer's amyloid precursor protein is mediated in part by the N-terminal region of A4 peptide.
    Buée L; Ding W; Anderson JP; Narindrasorasak S; Kisilevsky R; Boyle NJ; Robakis NK; Delacourte A; Greenberg B; Fillit HM
    Brain Res; 1993 Nov; 627(2):199-204. PubMed ID: 8298962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AA glomerular amyloid. An ultrastructural immunogold study of the colocalization of heparan sulphate proteoglycan and P component with amyloid fibrils together with changes in distribution of type IV collagen and fibronectin.
    Moss J; Shore I; Woodrow D
    Histopathology; 1994 May; 24(5):427-35. PubMed ID: 8088714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibronectin and basement membrane components in renal amyloid deposits in patients with primary and secondary amyloidosis.
    Westermark GT; Norling B; Westermark P
    Clin Exp Immunol; 1991 Oct; 86(1):150-6. PubMed ID: 1914228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental AA amyloidogenesis is associated with differential expression of extracellular matrix genes.
    Woodrow SI; Stewart RJ; Kisilevsky R; Gore J; Young ID
    Amyloid; 1999 Mar; 6(1):22-30. PubMed ID: 10211408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What role(s) may extracellular matrix, particularly heparan sulfate, play in amyloid of Alzheimer's disease.
    Benditt EP
    Neurobiol Aging; 1989; 10(5):506; discussion 510-2. PubMed ID: 2530463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A beta amyloidogenesis: unique, or variation on a systemic theme?
    Kisilevsky R; Fraser PE
    Crit Rev Biochem Mol Biol; 1997; 32(5):361-404. PubMed ID: 9383610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential binding of vascular cell-derived proteoglycans (perlecan, biglycan, decorin, and versican) to the beta-amyloid protein of Alzheimer's disease.
    Snow AD; Kinsella MG; Parks E; Sekiguchi RT; Miller JD; Kimata K; Wight TN
    Arch Biochem Biophys; 1995 Jun; 320(1):84-95. PubMed ID: 7793988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A temporal and ultrastructural relationship between heparan sulfate proteoglycans and AA amyloid in experimental amyloidosis.
    Snow AD; Bramson R; Mar H; Wight TN; Kisilevsky R
    J Histochem Cytochem; 1991 Oct; 39(10):1321-30. PubMed ID: 1940305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sulfate content and specific glycosaminoglycan backbone of perlecan are critical for perlecan's enhancement of islet amyloid polypeptide (amylin) fibril formation.
    Castillo GM; Cummings JA; Yang W; Judge ME; Sheardown MJ; Rimvall K; Hansen JB; Snow AD
    Diabetes; 1998 Apr; 47(4):612-20. PubMed ID: 9568695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implications of Heparan Sulfate and Heparanase in Amyloid Diseases.
    Li JP; Zhang X
    Adv Exp Med Biol; 2020; 1221():631-645. PubMed ID: 32274729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A high resolution ultrastructural study of experimental murine AA amyloid.
    Inoue S; Kisilevsky R
    Lab Invest; 1996 Mar; 74(3):670-83. PubMed ID: 8600318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.